tiprankstipranks

Benjamin Looker Insider Profile

4 Followers
Benjamin Looker, General Counsel at Trillium Therapeutics, holds ― shares in Trillium Therapeutics (Ticker: TRIL), holds 183.66K shares in Esperion (Ticker: ESPR). Most recently, Benjamin Looker ― shares of Trillium Therapeutics on ― for an estimated value of ―.
tipranks
Benjamin Looker

Benjamin Looker
Trillium Therapeutics (TRIL)
General Counsel

Ranked #44,296 out of 98,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+9.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$349K
100.00%
A breakdown of Benjamin Looker's holdings

Insider Roles

Esperion
(ESPR)
GC
Roles that Benjamin Looker holds in companies

Most Profitable Insider Trade

Stock:
Esperion
(ESPR)
Rating:Informative Sell
Date:Jan 19, 2023 - Jan 19, 2024
Return:+70.50%
The most profitable trade made by Benjamin Looker

Benjamin Looker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TRIL
Trillium Therapeutics
Esperion
Mar 15, 2024
GC
Uninformative Buy
$348.96K
List of latest transactions for each holding click on a transaction to see Benjamin Looker's performance on stock

Benjamin Looker insider profile FAQ

What is the percentage of profitable transactions made by Benjamin Looker?
The percentage of profitable transactions made by Benjamin Looker is 50%.
    What is the average return per transaction made by Benjamin Looker?
    The average return per transaction made by Benjamin Looker is 9.10%.
      What stocks does Benjamin Looker hold?
      Benjamin Looker holds: TRIL, ESPR stocks.
        What was Benjamin Looker’s latest transaction?
        Benjamin Looker latest transaction was an Uninformative Buy of ―.
          What was Benjamin Looker's most profitable transaction?
          Benjamin Looker’s most profitable transaction was an Informative Sell of ESPR stock on January 19, 2023. The return on the trade was 70.50%.
            What is Benjamin Looker's role in Trillium Therapeutics?
            Benjamin Looker's role in Trillium Therapeutics is General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.